A Retrospective Cross-Sectional Study of Bone Marrow Pathology Among the Elderly Population
DOI:
https://doi.org/10.21276/apalm.3903Keywords:
bone marrow morphology, geriatric hematologyAbstract
Background: India is experiencing a rapid demographic shift, with the elderly population (≥60 years) projected to reach 19.5% by 2050. This transition is accompanied by a rising burden of geriatric-specific hematological diseases, driven by age-related genetic alterations and comorbidities. Despite the clinical importance of bone marrow examination in diagnosing these complex conditions, comprehensive data from Eastern India remains sparse. This study aims to characterize the clinical profiles and determine the frequency of various bone marrow pathologies among elderly patients at a key tertiary care facility in West Bengal.
Methods: A retrospective cross-sectional study was conducted in a tertiary care teaching hospital of West Bengal, covering a four-year period (2020–2023). The study included patients aged 60 years and above who underwent bone marrow aspiration (BMA) and/or trephine biopsy. Researchers re-evaluated all morphology slides and preserved paraffin blocks. Hematological neoplasms were classified according to the latest WHO criteria. Data analysis for frequency estimation was performed using MS-Excel.
Result: Sixty cases were analyzed. Pancytopenia (51.67%) was the most common indication, followed by suspected leukemia (15%). Hypoplastic marrow was the most frequent diagnosis (21.67%; 95% CI: 13.1–33.6%). Primary haematological neoplasms accounted for 33.33% of cases, with acute myeloid leukemia and myelodysplastic neoplasm being the most common malignancies.
Conclusion: This study provides critical regional data for Eastern India, emphasizing the high frequency of hypoplastic marrow and the necessity of integrated marrow morphology to navigate the complex hematological landscape of the aging population.
References
1. International Institute for Population Sciences (IIPS), National Programme for Health Care of Elderly (NPHCE), MoHFW, Harvard T. H. Chan School of Public Health (HSPH) and the University of Southern California (USC) 2020. Longitudinal Ageing Study in India (LASI) Wave 1, 2017-18, India Report, International Institute for Population Sciences, Mumbai. Available from: https://www.iipsindia.ac.in/lasi
2. Dominique B, Lionel A, Tamas F, Valentin G, Reinhard S. Aging and blood disorders: new perspectives, new challenges. Haematologica. 2015;100(4):415-7. Available from: https://doi.org/10.3324/haematol.2015.126771
3. Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC, International Council for Standardization In H. ICSH guidelines for the standardization of bone marrow specimens and reports. International Journal of Laboratory Hematology. 2008;30(5):349-64. Available from: https://doi.org/10.1111/j.1751-553X.2008.01100.x
4. Singh A, Rawat S, Kushwaha R, Jain M, Verma SP, Verma N, et al. Bone marrow metastasis in nonhematological malignancies: A study from tertiary care center. Ann Afr Med. 2024;23(1):91-9. Available from: https://doi.org/10.4103/aam.aam_55_23
5. Ahsan E, Singh S, Kumar Gautam S, Chandra H, Balasubramanian P, Kumar Gupta A, et al. Granulomas in bone marrow: is it always tuberculosis? J Hematop. 2025;18(1):32. Available from: https://doi.org/10.1007/s12308-025-00647-5
6. Board WCoTE. Haematolymphoid tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2024. Available from: https://publications.iarc.who.int/Book-And-Report-Series/Who-Classification-Of-Tumours/Haematolymphoid-Tumours-2024
7. Shivashankara, Banerjee J, Mehrotra R, Wildes TM. Improving care for older adults with hematological malignancies in India: Conquering the challenge. J Geriatr Oncol. 2023;14(6):101536. Available from: https://doi.org/10.1016/j.jgo.2023.101536
8. Chandra H, Gupta AK, Arathi K, Bharati V, Singh N. Bone marrow examination in geriatric patients-An institutional experience from the north Himalayan region of India. J Family Med Prim Care. 2019;8(12):3931-4. Available from: https://doi.org/10.4103/jfmpc.jfmpc_792_19
9. Dolai TK, Jain M, Mahapatra M. Idiopathic Aplastic anemia: Indian Perspective. Indian J Hematol Blood Transfus. 2023;39(3):357-70. Available from: https://doi.org/10.1007/s12288-022-01592-4
10. Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, et al. Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline. British Journal of Haematology. 2024;204(3):784-804. Available from: https://doi.org/10.1111/bjh.19236
11. Singh V, Singh M, Shankar Singh P. Pancytopenia: etiologies and manifestation in eastern India. Int J Res Med Sci. 2017;5(12):5212-7. Available from: https://www.msjonline.org/index.php/ijrms/article/view/4219
12. Mohanty N, Kannan AN, Jain N. Clinical and hematological profile of pancytopenia in a tertiary care hospital of Southern Odisha, India. Int J Res Med Sci. 2019;7(4):1247-51. Available from: https://doi.org/10.18203/2320-6012.ijrms20191333
13. Dasgupta S, Mandal PK, Chakrabarti S. Etiology of Pancytopenia: An Observation from a Referral Medical Institution of Eastern Region of India. J Lab Physicians. 2015;7(2):90-5. Available from: https://doi.org/10.4103/0974-2727.163136
14. Sengupta S, Nayak P. Bicytopenia/pancytopenia cases in a tertiary care hospital of Jungalmahal: A search for etiology. Journal of Medical Science And Clinical Research. 2018;6. Available from: https://doi.org/10.18535/jmscr/v6i9.154
15. Tejeswini V, Premalatha P, Inuganti R, Krishna R, Pavkrichnamacharyulu, Vahini G. Clinicohaematological profile of Pancytopenia-A South Indian tertiary hospital experience. Indian Journal of Pathology and Oncology. 2015;2:165-9. Available from: https://doi.org/10.5958/2394-6792.2015.00013.7
16. Pendkur G, Singhal P, Somasundaram V, Raghavendra S, Sharma S. Clinicopathological Study of New Onset Pancytopenia: An Experience of Largest Study from a Tertiary Care Center of Western India. Medical Journal of Dr DY Patil Vidyapeeth. 2021;14(3):283-91. Available from: https://journals.lww.com/mjdy/fulltext/2021/14030/clinicopathological_study_of_new_onset.9.aspx
17. Gulati A, Mandal T, Kaushal V, Kaushik R, Thakur S. Bone Marrow Disease Profile in Geriatric Patients: An Institutional Experience. Indian J Hematol Blood Transfus. 2018;34(3):540-3. Available from: http://europepmc.org/abstract/MED/30127568
18. Srijanaki M JMJ, Shantaraman K, Swaminathan K. A Study to Evaluate the Bone Marrow Changes in Geriatric Patients with Anemia. International Journal of Health Sciences and Research. 2016;6(11):57-66. Available from: https://www.ijhsr.org/IJHSR_Vol.6_Issue.11_Nov2016/9.pdf
19. Singh S, Lionel S, Jain H, Nayak L, Selvarajan S, Samuel P, et al. Real World Data on Unique Challenges and Outcomes of Older Patients with AML from Resource Limited Settings: Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC). Blood. 2022;140(Supplement 1):6096-8. Available from: https://doi.org/10.1182/blood-2022-167099
20. Jani CT, Ahmed A, Singh H, Mouchati C, Al Omari O, Bhatt PS, et al. Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study. JCO Global Oncology. 2023(9):e2300229. Available from: https://doi.org/10.1200/GO.23.00229
21. Woods JD, Klepin HD. Geriatric Assessment in Acute Myeloid Leukemia. Acta Haematol. 2024;147(2):219-28. Available from: https://doi.org/10.1159/000535500
22. Hellström-Lindberg ES, Kröger N. Clinical decision-making and treatment of myelodysplastic syndromes. Blood. 2023;142(26):2268-81. Available from: https://doi.org/10.1182/blood.2023020079
23. Oster HS, Mittelman M. How we diagnose Myelodysplastic syndromes. Front Oncol. 2024;14:1415101. Available from: https://doi.org/10.3389/fonc.2024.1415101
24. Oster HS, Van de Loosdrecht AA, Mittelman M. Diagnosis of myelodysplastic syndromes: the classic and the novel. Haematologica. 2025;110(2):300-11. Available from: https://doi.org/10.3324/haematol.2023.284937
25. Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(8):1086-107. Available from: https://doi.org/10.1002/ajh.26590
26. Urban VS, Cegledi A, Mikala G. Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment. Geroscience. 2023;45(2):727-46. Available from: https://doi.org/10.1007/s11357-022-00698-x
27. Facon T, Leleu X, Manier S. How I treat multiple myeloma in geriatric patients. Blood. 2024;143(3):224-32. Available from: https://doi.org/10.1182/blood.2022017635
28. Nasnas P, Cerchione C, Musuraca G, Martinelli G, Ferrajoli A. How I Manage Chronic Lymphocytic Leukemia. Hematol Rep. 2023;15(3):454-64. Available from: https://doi.org/10.3390/hematolrep15030047
29. Soumerai JD, Barrientos J, Ahn I, Coombs C, Gladstone D, Hoffman M, et al. Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL. Blood Advances. 2025;9(5):1213-29. Available from: https://doi.org/10.1182/bloodadvances.2024014474
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Debanjan Bhattacharjee, Soumya Kundu, Pamela Nayak
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
